skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
Issue Dt:
03/18/2003
Application #:
10031760
Filing Dt:
05/08/2002
Inventors:
Alexander Mark Gibson, Marivi Mendizabal, Richard Pither, Shirley Elizabeth Pullan et al
Title:
RADIOLABELLED BISPHOSPHONATES AND METHOD
Assignment: 1
Reel/Frame:
012893/0661Recorded: 05/13/2002Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
03/05/2002
Exec Dt:
03/05/2002
Exec Dt:
03/08/2002
Exec Dt:
03/05/2002
Exec Dt:
03/04/2002
Exec Dt:
03/04/2002
Assignee:
THE GROVE CENTRE, WHITE LION ROAD
AMERSHAM, BUCKINGHAMSHIRE, GREAT BRITAIN HP7 9
Correspondent:
AMERSHAM BIOSCIENCES CORP.
ROYAL N. RONNING, JR.
800 CENTENNIAL AVENUE
PISCATAWAY, NJ 08855
Assignment: 2
Reel/Frame:
016891/0728Recorded: 10/18/2005Pages: 3
Conveyance:
CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
08/25/2005
Assignee:
AMERSHAM PLACE
LITTLE CHALFONT
BUCKINGHAMSHIRE HP7 9NA, UNITED KINGDOM
Correspondent:
AMERSHAM HEALTH, INC.
ROBERT F. SHISHOLM
101 CARNEGLE CENER
IP DEPARTMENT
PRINCETON, NJ 08540
Assignment: 3
Reel/Frame:
017073/0846Recorded: 11/30/2005Pages: 3
Conveyance:
CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
08/25/2005
Assignee:
LITTLE CHALFONT
AMERSHAM PLACE, LITTLE CHALFONT
BUCKINGHAMSHIRE, HP7 9NA, UNITED KINGDOM
Correspondent:
ROBERT F. CHISHOLM
AMERSHAM HEALTH, INC.
IP DEPARTMENT
101 CARNEGIE CENTER
PRINCETON, NJ 08540

Search Results as of: 06/19/2024 09:10 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT